Literature DB >> 6430307

Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease.

H Kukita, K Hiwada, T Kokubu.   

Abstract

Serum cholesterol, triglyceride, high density lipoprotein cholesterol (HDL-C) and apolipoprotein (apo) A-I, A-II and B concentrations were measured in 109 first-degree relatives of patients with angiographically defined coronary artery disease (CAD). Age- and sex-matched healthy factory employees were chosen as a control group. Male relatives of the CAD patients had significantly higher serum triglyceride and apoB levels, and significantly lower serum HDL-C and apoA-I levels than the controls. Female relatives of the CAD patients also showed similar differences in serum HDL-C, apoA-I and apoB levels. Discriminant analysis indicated that apolipoproteins were better discriminators than lipids in both patients with CAD and their relatives. In univariate analysis, the best discriminator was apoB between male relatives and the controls, and apoA-I between female relatives and the controls. The percentage of exact classification achieved using three variables (serum cholesterol, triglyceride and HDL-C) was 74% in male relatives and 70% in female relatives. By adding variables of apoA-I and apoB, the percentage of correctly classified subjects was increased to 82% and 80%, respectively. These results indicate that serum apolipoprotein abnormalities are prevalent in relatives of the CAD patients. These abnormalities may explain the familial aggregation of CAD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430307     DOI: 10.1016/0021-9150(84)90173-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

2.  Serum lipoproteins in day and shift workers: a prospective study.

Authors:  A Knutson; H Andersson; U Berglund
Journal:  Br J Ind Med       Date:  1990-02

3.  The genetic determination of plasma apolipoprotein A-I levels measured by radioimmunoassay: a study of high-risk pedigrees.

Authors:  P P Moll; C F Sing; R R Williams; S J Mao; B A Kottke
Journal:  Am J Hum Genet       Date:  1986-03       Impact factor: 11.025

4.  Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population.

Authors:  Hendrick E van Deventer; W Greg Miller; Gary L Myers; Ikunosuke Sakurabayashi; Lorin M Bachmann; Samuel P Caudill; Andrzej Dziekonski; Selvin Edwards; Mary M Kimberly; William J Korzun; Elizabeth T Leary; Katsuyuki Nakajima; Masakazu Nakamura; Robert D Shamburek; George W Vetrovec; G Russell Warnick; Alan T Remaley
Journal:  Clin Chem       Date:  2011-01-12       Impact factor: 8.327

5.  Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction.

Authors:  M Sewdarsen; R K Desai; S Vythilingum; N Shah; M C Rajput
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

6.  Lipid profile in alcohol dependence.

Authors:  M Vaswani; P Hemraj; N G Desai; B M Tripathi
Journal:  Indian J Psychiatry       Date:  1997-01       Impact factor: 1.759

Review 7.  Green tea catechins and cardiovascular health: an update.

Authors:  Pon Velayutham Anandh Babu; Dongmin Liu
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.

Authors:  M Barbir; D Wile; I Trayner; V R Aber; G R Thompson
Journal:  Br Heart J       Date:  1988-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.